Income statement, balance sheet and cash flow statement for the last 5 fiscal years, taken from the XBRL data OmniAb, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
34.7
59.1
34.2
26.4
18.7
Research and development
39.2
48.4
56.5
55.1
47.8
General and administrative
16.9
24.9
33.3
30.7
29.2
Operating expenses
70.4
85.7
104
101
87.6
Operating income
-35.6
-26.6
-69.4
-74.5
-69
Interest expense
0.01
0
Interest income
0
0.59
5.06
3.11
2.66
Other non-operating income
1.26
0.59
5.06
3.09
2.68
Pre-tax income
-34.4
-26.1
-64.4
-71.4
-66.3
Income tax
-7.31
-3.73
-13.7
-9.38
-1.52
Net income
-27
-22.3
-50.6
-62
-64.8
EBITDA
-19.4
-8.4
-49.9
-50.9
-47.2
EPS, basic
-0.33
-0.26
-0.51
-0.61
-0.57
EPS, diluted
-0.33
-0.26
-0.51
-0.61
-0.57
Shares, basic (weighted)
82.6
85.3
99.7
102
114
Shares, diluted (weighted)
82.6
85.3
99.7
102
114
Balance sheet
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
0
33.4
16.4
27.6
25.5
Short-term investments
0
54.9
70.6
31.8
28.5
Receivables
21.1
30.3
3.84
5.27
7.39
Inventory
0.05
0.82
Other current assets
1.41
6.4
4.07
1.09
1.11
Total current assets
22.5
125
94.9
68.1
65.3
Property, plant and equipment
6.8
20
18.2
15.5
9.43
Lease right-of-use assets
13.3
21.5
19.9
17.8
15.5
Goodwill
84
84
84
84
84
Intangible assets
176
167
155
138
125
Other non-current assets
1.5
3.13
2.19
1.54
0.91
Total assets
304
421
375
326
301
Accounts payable
2.92
2.97
4.41
2.3
1.88
Accrued liabilities
3.75
5.56
7.07
6.14
6.29
Deferred revenue
10.8
8.21
6.85
2.34
3.16
Total current liabilities
20.6
26
23.1
15.1
16.3
Lease liabilities
13.3
24
22.1
19.4
16.5
Other non-current liabilities
0.3
0.05
0.03
0.09
0.08
Total liabilities
70.2
79.8
60.6
37.9
33.9
Paid-in capital
0
330
354
389
433
Retained earnings
0
11.3
-39.4
-101
-166
Other comprehensive income
0
0.01
0.05
0.03
0.01
Shareholders' equity
234
341
315
288
267
Total equity
234
341
315
288
267
Total liabilities and equity
304
421
375
326
301
Shares outstanding
0
115
117
122
144
Cash flow statement
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-27
-22.3
-50.6
-62
-64.8
Depreciation and amortization
16.3
18.2
19.5
23.6
21.8
Stock-based compensation
15.1
18.3
24.8
21.5
15.8
Deferred income tax
-7.33
-7.25
-12.8
-9.04
-1.53
Change in receivables
6.02
-12.7
26.9
-0.63
0.19
Change in payables
1.51
15.1
0.92
-2.41
-0.23
Cash from operations
-5.67
-3.59
2.35
-39.7
-36.5
Capital expenditures
-4.07
-17.2
-1.64
-1.88
-0.57
Purchases of investments
0
-54.8
-113
-40.3
-46.9
Sales and maturities of investments
1.27
0
96.9
78
50.8
Cash from investing
-4.03
-73.3
-18.4
37.9
6.47
Stock issued
0
96.2
0
11.4
0
Cash from financing
9.7
111
-0.89
13
27.9
Net change in cash
0
33.8
-16.9
11.2
-2.07
Free cash flow
-9.74
-20.8
0.7
-41.5
-37
Income taxes paid
0
2.61
0.02
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $4.61 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Operating margin
-125.8%
Operating income / revenue.
EBITDA margin
-100.3%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-118.9%
Pre-tax income / revenue.
Net margin
-115.1%
Net income / revenue.
FCF margin
-47.2%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-46.0%
Cash from operations / revenue.
Return on equity (ROE)
-17.0%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-15.3%
Net income / average total assets.
Return on invested capital (ROIC)
-16.2%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
113.2%
Research and development expense / revenue.
Stock-based pay / revenue
36.6%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
1.2%
Capital expenditures / revenue.
D&A / revenue
25.5%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-29.3%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-31.9%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y
-7.2%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-7.9%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y
-7.6%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-10.6%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y
11.0%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
10.0%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
4.80x
Current assets / current liabilities.
Quick ratio
4.53x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
3.78x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$0.30
Revenue / diluted weighted shares.
FCF per share
-$0.14
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.14
Cash from operations / diluted weighted shares.
Book value per share
$1.79
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
17.4x
Market cap / revenue.
P/B
2.58x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
11.1x
Market cap / tangible book value, when positive.
EV/Sales
16.1x
Enterprise value / revenue.
FCF yield
-2.7%
Free cash flow / market cap.
Earnings yield
-6.6%
Net income / market cap (the inverse of P/E).
What was OmniAb, Inc.'s revenue in fiscal 2025?
OmniAb, Inc. reported revenue of $18.7M for fiscal 2025, 29.3% lower than the year before.
Was OmniAb, Inc. profitable in fiscal 2025?
No. It reported a net loss of $64.8M.
How much free cash flow did OmniAb, Inc. generate in fiscal 2025?
Cash from operations of $36.5M minus capital expenditures of $565.0K left free cash flow of -$37.0M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.